10.07.2015 Views

Dicembre Vol.3 N° 3 - 2007 - Salute per tutti

Dicembre Vol.3 N° 3 - 2007 - Salute per tutti

Dicembre Vol.3 N° 3 - 2007 - Salute per tutti

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

A. Sparavigna A, R. Forte, F.S. DioguardiFigure 1.R esultsClinical evaluationsTo l e r a n c e - The tolerance of thetested products was judged as very good and noadverse event occurred during the study <strong>per</strong>iod(final investigators’ opinion: 81%= excellent,18%= good).The good tolerance was confirmed by thevolunteers’ opinion; as a matter of fact, only fewsubjects underlined the appearance of a slighterythema with a burning sensation followingthe first cream and/or liquid patch applicationand lasting few minutes.Clinical evaluations <strong>per</strong>formed during the entiretreatment <strong>per</strong>iod demonstrated the absenceof relevant clinical signs as erythema, oedema,papules, pustules or the like.Clinical evaluation of efficacy - The evaluationof the efficacy of the treatment under studytook into account the above mentioned agingsigns. An example of treatment efficacy isshown in F i g u re 1. The statistical evaluation ofthe clinical data was <strong>per</strong>formed using theWilcoxon test. One month after the last intradermalimplant (T1), a significant and importantimprovement of nasolabial folds (p

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!